Rasha Al-Lamee, MD, PhD, BSc
Planning Committee Member
1. Philips, Abbott Vascular, Medtronic, Menarini, Omniprex
2. CathWorks, Janssen Pharmaceuticals
1. Speaker honorarium
2. Advisory Board
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, is fair-balanced, and is based on scientific evidence and/or clinical reasoning
María Cecilia Bahit, MD
Planning Committee Member
1. Anthos Therapeutics, BMS/Pfizer, Janssen/Johnson & Johnson, Merck
1. Academic consulting, committee work, membership on grant application review groups, and honoraria
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, is fair-balanced, and is based on scientific evidence and/or clinical reasoning
Jonathan Coutinho, MD, PhD, FESO
Planning Committee Member
1. AstraZeneca, Bayer, Siemens
1. Contracted research
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, is fair-balanced, and is based on scientific evidence and/or clinical reasoning
David Gailani, MD
Planning Committee Member, Faculty
1. Anthos Therapeutics, Bayer Pharma, Bristol-Myers Squibb, Ionis, Janssen
2. Anthos Therapeutics, Bayer Pharma, Bristol-Myers Squibb, Ionis, Janssen
1. Non-CE Consulting
2. Received honoraria and travel support from some of the listed companies
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, is fair-balanced, and is based on scientific evidence and/or clinical reasoning
Clay Johnston, MD, PhD
Planning Committee Member
1. Solay, Kisbee
2. Johnson & Johnson, BMS
1. Non-CE consulting
2. Contract research
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, is fair-balanced, and is based on scientific evidence and/or clinical reasoning
Carolyn S.P. Lam, MD, PhD
Planning Committee Member
1. Alleviant Medical, Allysta Pharmaceutical, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Biopeutics, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CardioRenal, CPC Clinical Research, Eli Lilly, Hanmi, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development LLC, Merck, Novartis, Novo Nordisk, ProSciento Inc., Quidel Corporation, Radcliffe Group Ltd., Recardio Inc., ReCor Medical, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics, Us2.ai
2. Novo Nordisk, Roche Diagnostics
3. Us2.ai
4. Patent pending
1. Academic consulting, membership on grant application review groups and honoraria
2. Contract Research
3. Stock ownership
4. Patent pending: PCT/SG2016/050217
Method for diagnosis and prognosis of chronic heart failure
US Patent No. 10,702,247
Automatic clinical workflow that recognizes and analyzes 2-dimensional and Doppler echo images for cardiac measurements and the diagnosis, prediction, and prognosis of heart disease
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, is fair-balanced, and is based on scientific evidence and/or clinical reasoning
Tzu-Fei Wang, MD, MPH
Planning Committee Member
No relevant financial relationships
N/A
N/A
Wolfgang C. Winkelmayer, MD, MPH, ScD, FASN
Planning Committee Member
1. Akebia, Anthos, Ardelyx, AstraZeneca, Bayer,
Boehringer Ingelheim, Cadrenal, GlaxoSmithKline, Natera, Novartis, Pharmacosmos, Unicycive, Vera
2. Bayer, Merck Sharpe Dohme
1. Non-CE consulting
2. Contract research
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Jeffrey Weitz, MD
Planning Committee Member, Faculty
1. Alnylam, Anthos Therapeutics, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Ionis, Daiichi-Sankyo, Johnson & Johnson, Merck, Novartis, Pfizer, Regeneron
1. Non-CE consulting
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted planning committee member
Content was reviewed by a non-conflicted content reviewer to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Amanda Noe
TFF Staff
No relevant financial relationships
N/A
N/A
Cary Clark
ISTH Staff
No relevant financial relationships
N/A
N/A
Nathan Koenning
ISTH Staff
No relevant financial relationships
N/A
N/A
Debra Fernandez
TFF Staff
No relevant financial relationships
N/A
N/A
Heather Tarbox, MPH
TFF Staff
No relevant financial relationships
N/A
N/A
Melissa Glasner, MS
TFF Staff
No relevant financial relationships
N/A
N/A
Miriam Giles
TFF Staff
No relevant financial relationships
N/A
N/A
